We are live on ! Find out more
GC

Gould Capital Portfolio holdings

AUM $179M
1-Year Est. Return 23.23%
This Fund
S&P 500
This Quarter Est. Return
+9.58%
1 Year Est. Return
+23.23%
3 Year Est. Return
+60.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$179M
AUM Growth
+$14.2M
Cap. Flow
+$2.13M
Cap. Flow %
1.18%
Top 10 Hldgs %
49.29%
Holding
221
New
17
Increased
55
Reduced
25
Closed
4

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$1.39M
2
RKT icon
Rocket Companies
RKT
+$912K
3
MSFT icon
Microsoft
MSFT
+$821K
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$778K
5
VZ icon
Verizon
VZ
+$627K

Top Sells

Rank Stock Value
1
DELL icon
Dell
DELL
+$2.35M
2
CAT icon
Caterpillar
CAT
+$1.38M
3
LRCX icon
Lam Research
LRCX
+$815K
4
PWR icon
Quanta Services
PWR
+$677K
5
BNDW icon
Vanguard Total World Bond ETF
BNDW
+$431K

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.79%
2 Technology 10.87%
3 Financials 9.38%
4 Communication Services 6.76%
5 Industrials 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAK icon
201
Takeda Pharmaceutical
TAK
$57.8B
$1.12K ﹤0.01%
70
– –
NAT icon
202
Nordic American Tanker
NAT
$1.53B
$1.11K ﹤0.01%
200
-12,500
-98% -$70.8K
VNQ icon
203
Vanguard Real Estate ETF
VNQ
$37.2B
$1.06K ﹤0.01%
11
– –
DIA icon
204
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$44.8B
$1.04K ﹤0.01%
2
– –
VBIL
205
Vanguard 0-3 Month Treasury Bill ETF
VBIL
$11.4B
$984 ﹤0.01%
13
– –
PRTA icon
206
Prothena Corp
PRTA
$463M
$979 ﹤0.01%
100
– –
FOX icon
207
Fox Class B
FOX
$24.4B
$937 ﹤0.01%
20
– –
EBS icon
208
Emergent Biosolutions
EBS
$301M
$838 ﹤0.01%
100
– –
IYH icon
209
iShares US Healthcare ETF
IYH
$3.57B
$804 ﹤0.01%
12
– –
EXR icon
210
Extra Space Storage
EXR
$28.8B
$727 ﹤0.01%
5
-50
-91% -$7.15K
AIPO
211
Defiance AI & Power Infrastructure ETF
AIPO
$881M
$668 ﹤0.01%
20
– –
SPOT icon
212
Spotify
SPOT
$107B
$459 ﹤0.01%
1
– –
SLV icon
213
iShares Silver Trust
SLV
$30.9B
$428 ﹤0.01%
8
– –
CROX icon
214
Crocs
CROX
$5.22B
$362 ﹤0.01%
3
– –
BITU icon
215
ProShares Ultra Bitcoin ETF
BITU
$483M
$325 ﹤0.01%
40
– –
GEHC icon
216
GE HealthCare
GEHC
$29B
$128 ﹤0.01%
2
– –
LCID icon
217
Lucid Motors
LCID
$1.65B
$47 ﹤0.01%
7
– –
BMY icon
218
Bristol-Myers Squibb
BMY
$130B
– –
-160
Closed -$9.72K
IBRX icon
219
ImmunityBio
IBRX
$8.18B
– –
-117
Closed -$897
MMM icon
220
3M
MMM
$84B
– –
-71
Closed -$10.3K
IPST
221
IP Strategy Holdings
IPST
$2.71M
– –
-1
Closed -$6
5 6 7 8
9

Similar funds

BRWM
Blue Rock Wealth Management Winston-Salem, North Carolina $179M AUM 24.01% 1-Year Est. Return
IWM
IMG Wealth Management Jacksonville, Florida $180M AUM 21.06% 1-Year Est. Return
WA
Watchtower Advisors Old Greenwich, Connecticut $180M AUM 81.98% 1-Year Est. Return
CCM
Cox Capital Management Andover, Massachusetts $180M AUM 40.44% 1-Year Est. Return
UA
URS Advisory Jupiter, Florida $180M AUM
GPA
Guerra Pan Advisors Montclair, New Jersey $179M AUM 40.97% 1-Year Est. Return
BBA
Braun-Bostich & Associates Canonsburg, Pennsylvania $179M AUM 21.93% 1-Year Est. Return
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $179M AUM

Gould Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Gould Capital held 221 positions worth $179M, up 8.6% from $165M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Gould Capital's Q2 2026 filing shows 17 new, 55 increased, 25 reduced and 4 closed positions. Its largest new stake was Neurocrine Biosciences: 9,390 shares worth $1.58M. The largest sale was Dell, an estimated $2.35M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Financials.

  • Gould Capital's largest Q2 2026 buy was Neurocrine Biosciences: 9,390 shares worth $1.58M.
  • Gould Capital added most to Rocket Companies in Q2 2026, an estimated $912K increase.
  • Gould Capital's biggest Q2 2026 reduction was Dell, cutting an estimated $2.35M.
  • Gould Capital fully exited 3M in Q2 2026, selling an estimated $10.3K.
  • Gould Capital's ten largest holdings make up 49% of its $179M portfolio in Q2 2026.
  • Gould Capital opened 17 new positions and closed 4 in Q2 2026.
  • Gould Capital's portfolio value rose 8.6% quarter-over-quarter to $179M.

Based on Gould Capital's 13F filing for Q2 2026, filed 7 Aug 2026.